Archive for September 19th, 2021

Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations

Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations

19-Sep-2021 Intellasia | BusinessWire | 10:30 PM

Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation at ESMO TROPION-Lung05 phase 2 trial currently [...] » More

Chinese Mooncakes Experience Booming Sales in the US with Great Acclaim from Local Consumers

19-Sep-2021 Intellasia | PR Newswire Asia | 8:00 PM

BEIJING and LOS ANGELES, Sept. 19, 2021 /PRNewswire/ -- A news report from CRI Online:   "I like it though." "It tastes like [...] » More

The World Clean Earth Day Comes, Guangdong Quadrant Takes Actions

The World Clean Earth Day Comes, Guangdong Quadrant Takes Actions

19-Sep-2021 Intellasia | PR Newswire Asia | 8:30 AM

SHANTOU, China, Sept. 19, 2021 /PRNewswire/ -- The World Clean Earth Day, also known as the World Clean Day, set on the third weekend of [...] » More

Michell Suharli, CEO of ShineWing Indonesia: Asia’s Most Admirable Young Leaders.

Michell Suharli, CEO of ShineWing Indonesia: Asia’s Most Admirable Young Leaders.

19-Sep-2021 Intellasia | PR Newswire Asia | 8:00 AM

SINGAPORE, Sept. 19, 2021 /PRNewswire/ -- The Asia Corporate Excellence & Sustainability Awards (ACES AWARDS) consistently recognizes [...] » More

CStone presents preliminary results from a phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with the anti-PD-1 mAb CS1003 in patients with advanced solid tumors at ESMO 2021

19-Sep-2021 Intellasia | PR Newswire Asia | 8:00 AM

SUZHOU, China, Sept. 19, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company [...] » More